Prevagen Maker Must Stop Using Memory Aid Marketing Statements

Prevagen maker Quincy Bioscience Holding Co. Inc. and its co-founder must stop using eight marketing claims that promote the jellyfish-based memory aid wherever it’s marketed nationwide, a federal judge said.

Quincy and co-founder Mark Underwood violated the Federal Trade Commission Act, which forbids false advertising and unfair or deceptive acts, said Judge Louis L. Stanton of the US District Court for the Southern District of New York on Dec. 6, affirming the injunction he ordered Nov. 18.

“Each of the Challenged Statements asserts similar, unsupported claims regarding memory or cognition, and although only two statements were materially misleading, all have ...